Dr Darrin Disley
CEO, Horizon Discovery
Dr Darrin M Disley is the CEO of Horizon Discovery, a world leader in gene editing and gene modulation technologies which are used to design and engineer cells. These cells underpin an extensive range of products and related research services, supporting a greater understanding of the function of genes and the genetic drivers of human disease and the development of molecular, cell and gene therapies. Horizon’s offerings have been adopted by over 10,000 academic, drug discovery, drug manufacturing and diagnostics customers around the globe. In 2014 the business achieved the biggest ever IPO for a company based in Cambridge’s ‘Silicon Fen’.
Beyond Horizon, Darrin is a champion of UK life sciences and is a strong supporter of young entrepreneurial talent through numerous academic, business, and mentoring programmes including funding the Carpe Diem Enterprise Program which funds entrepreneurship training, mentorship and the founding of numerous life science, technology and software companies.
In recognition of his contribution to Life Science entrepreneurship, Darrin received the Queens Award for Enterprise Promotion in 2016.